These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7906451

  • 1. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
    Rossen K, Hou-Jensen K, Werdelin O.
    Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
    Goette DK, Helwig EB.
    Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
    [Abstract] [Full Text] [Related]

  • 10. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
    Lindboe CF, Løvdal L.
    Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
    [Abstract] [Full Text] [Related]

  • 11. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME, Smith K, Corbett D, Skelton HG.
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [Abstract] [Full Text] [Related]

  • 12. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
    Habets JM, Tank B, Vuzevski VD, Stolz E, van Joost T.
    J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
    [Abstract] [Full Text] [Related]

  • 13. Basal cell carcinoma overlying a dermatofibroma: a revisited controversy.
    Rosmaninho A, Farrajota P, Peixoto C, Amorim I, Selores M.
    Eur J Dermatol; 2011 Jan; 21(1):137-8. PubMed ID: 21233074
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dermatofibroma: upregulation of syndecan-1 expression in mesenchymal tissue.
    Sellheyer K, Smoller BR.
    Am J Dermatopathol; 2003 Oct; 25(5):392-8. PubMed ID: 14501288
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunohistologic study of cellular populations of histiocytofibromas ("dermatofibromas").
    Kanitakis J, Schmitt D, Thivolet J.
    J Cutan Pathol; 1984 Apr; 11(2):88-94. PubMed ID: 6330187
    [Abstract] [Full Text] [Related]

  • 18. Solitary sclerotic fibroma of the skin: a sclerotic dermatofibroma?
    Pujol RM, de Castro F, Schroeter AL, Su WP.
    Am J Dermatopathol; 1996 Dec; 18(6):620-4. PubMed ID: 8989937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sebaceous hyperplasia overlying a dermatofibroma.
    Davis TT, Calilao G, Fretzin D.
    Am J Dermatopathol; 2006 Apr; 28(2):155-7. PubMed ID: 16625080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.